Abstracts

1. Call for Abstracts for the International Session

• We are now accepting abstracts for the International Session at the 18th Annual Conference of the Japan Primary Care Association. We welcome submissions from a wide range of professionals and students contributing to primary health care.
• All International Session presentations and discussions will be in English.
• One Best Investigator Award (open to all presenters regardless of profession) and one Young Investigator Award (for Japanese presenters under 40 at the time of abstract submission) will be presented to outstanding presentations in the International Session. These awards aim to promote the internationalization of primary care research in Japan.
• Please be sure to read the following instructions before submitting your abstract.

2. Dates of the International Session

May 22 (Sat.) – May 23 (Sun.), 2027

(The conference itself will be held from May 21 to May 23, 2027.)

3. Abstract Submission Period

October 14 (Wed.), 2026, 11:00 – December 7 (Mon.), 2026, 12:00 noon (JST)

Please submit your abstract within the above period.

4. Presentation

• The International Session accepts Research, Case Report, and Activity Report submissions.
• Presentation format: Research will, in principle, be presented orally; Case Report and Activity Reports will, in principle, be presented as posters.

4-a Abstract Categories

In principle, the criteria for "Research," "Case Report," and "Activity Report" follow the Submission Rules for the Journal of the Japan Primary Care Association. Please refer to 1) of "5. Classification, Structure, and Contents of Papers" in the submission rules.

Research

• In principle, Research will be presented orally.
• Research includes quantitative, qualitative, or mixed-methods studies and must be completed by the day of the presentation.
• Please structure your abstract according to the Research / Hinohara Award Structured Abstract Format. (in Japanese) You may omit items that do not apply to your research.

Case Report

• In principle, Case Reports will be presented as posters.
• A Case Report is a detailed report or case series on the diagnosis, treatment, and course of an individual case.
• Please structure your abstract with the following sections: [Background], [Case], and [Discussion].

Activity Report

• In principle, Activity Reports will be presented as posters.
• An Activity Report describes activities related to improving the quality of care, practice management, community engagement, and similar areas.
• Please structure your abstract with the following sections: [Background], [Activities], and [Discussion].

4-b Presentation Formats

Oral Presentation

• Oral presentations will be given on site at the conference venue using PowerPoint or similar software.
• Details on presentation and discussion times will be announced later.

Poster Presentation

• Poster presentations will be in e-Poster format. Please upload your presentation data to the online system before the conference. On the day of the conference, you will present using your data displayed on a monitor at the venue. Printed posters will not be displayed on poster boards.
• Details on presentation times and guidelines for preparing your presentation data will be announced later.

5. General Requirements for Submissions

5-a Ethical Considerations and Privacy Protection

• Presenters who are planning to conduct clinical research should, before applying for ethics review, confirm that their study has been designed in accordance with the Ethical Guidelines for Life Science and Medical Research Involving Human Subjects (in Japanese) issued by the Ministry of Education, Culture, Sports, Science and Technology; the Ministry of Health, Labour and Welfare; and the Ministry of Economy, Trade and Industry.

Privacy Protection

• To protect personal information, do not include any information that could identify patients or other individuals in your submission.
• For presentations that include patient information, please give full consideration to patient privacy and obtain informed consent before submitting your abstract.

Ethical Considerations

• For studies that require approval from an ethics committee or similar body under the Ethical Guidelines for Life Science and Medical Research Involving Human Subjects or other guidelines on medical research, please obtain the necessary ethics review and approval, and then select the applicable item in the "Ethical Considerations" section of the online submission system.
• If your institution's regulations require notification, confirmation, or other procedures, please complete them as required.

5-b Presentation Data

Please review the handling of presentation data (in Japanese), before submitting.

5-c Duplicate Presentation, Withdrawal, and Change of Presenter

Prohibition of Duplicate Presentation

• Work that has been or will be presented at another conference or meeting (as an oral or poster presentation), or whose identical content has already been published or made publicly available as a full paper in a peer-reviewed journal or similar publication at the time of abstract submission, is not eligible for submission.
• Work that is currently submitted to, under review by, or under revision for another journal or conference, or that has not been accepted, is eligible for submission. Work that has been accepted but not yet published, or that is available as a preprint, is also eligible.
• If your paper is published after you submit your abstract, you do not need to withdraw your abstract. However, please notify the Secretariat promptly and clearly state this in your presentation (e.g., on your slides).

Withdrawal and Change of Presenter

• In principle, accepted abstracts may not be withdrawn.
• If you must withdraw your abstract due to unavoidable circumstances, please submit a written statement of reasons (in any format) to the Secretariat in advance and complete the required procedures.
• If the first author is unable to present, a co-author may present on their behalf. In this case, please also submit a written statement of reasons (in any format) to the Secretariat in advance and complete the required procedures.
• Presenters who change the presenter without completing the required procedures, fail to register their e-Poster data by the deadline, withdraw without notice, or do not give their presentation may be restricted from presenting at future conferences.

5-d Maximum Number of Speaking Roles

To give more people the opportunity to speak, each person may take a speaking role in no more than two sessions. The count includes speakers, chairs, and panelists in open-call sessions, chairs of general abstract sessions, and first authors of general abstracts. Multiple roles in the same session count as one. The count does not include roles in sessions organized by or at the request of the Organizing Committee, session organizers who do not speak on the day, co-authors of general abstracts, or roles in on-demand-only sessions. Please check and manage your own total.

6. Disclosure of Conflicts of Interest (COI)

All presenters at the 18th Annual Conference of the Japan Primary Care Association must disclose the conflicts of interest of the first author and all co-authors. When submitting your abstract, the first author should enter this information on behalf of all co-authors. Before entering it, please be sure to confirm each co-author’s COI status with them.
Please review the following and answer the “Conflicts of Interest” section in the online submission system. The COI items have been changed for this conference as follows.

• Academic COI
  The items “Occupation” and “Primary Practice Setting or Affiliation” have been added. For “Primary Practice Setting or Affiliation,” please select the setting where the presenter primarily works or with which they are affiliated, not the facility where the presented study was conducted.
• Presentation Content and Commercial Involvement
  Presentations that could be regarded as commercial advertising intended to promote the sale or use of specific products, services, or projects are not permitted. Do not include information directly related to purchasing, such as prices, how to purchase or contract, contract terms, discounts, or where to apply.
  In addition, any involvement by a presenter or their immediate family members in the development, provision, or sale of products, services, systems, or similar items discussed in the presentation will be checked as part of the financial COI items.
• Financial COI
  In addition to the existing items (1–9) specified in the disclosure items (Detailed Regulations of the COI Management Guidelines) (in Japanese), item 10 has been newly added for this conference.
  1. Compensation as a director, advisor, etc. (more than ¥1,000,000 per year from a single company or organization)
  2. Profit from stock (more than ¥1,000,000 per year from a single company, or ownership of more than 5% of the company's shares)
  3. Patent royalties, etc. (a total of ¥1,000,000 or more per year from a single company or organization)
  4. Lecture fees, etc. (a total of ¥1,000,000 or more per year from a single company or organization)
  5. Manuscript fees, etc. (a total of ¥1,000,000 or more per year from a single company or organization)
  6. Research expenses, grants, etc. (a total of more than ¥2,000,000 per year from a single company or organization for one clinical study)
  7. Financial support (a total of more than ¥2,000,000 per year from a non-profit company or organization)
  8. Scholarship donations (more than ¥2,000,000 per year from a single company or organization to one principal investigator)
  9. Other benefits, such as travel expenses or gifts (a total of ¥100,000 or more per year from a single company or organization)
  10. (New) Involvement in the development, provision, or sale of products, services, systems, or similar items discussed in the presentation (regardless of whether any compensation was received and regardless of the type or size of the organization)
      If this applies, please provide the name of the company or organization and the presenter’s role (e.g., founder, executive, employee, investor, advisor, license holder, or development collaborator).

  If none of items 1–9 apply and only item 10 applies, please also select “I have COI to disclose.”
  For items 1–9, please answer according to the existing criteria.

COI Disclosure at the Conference

The COI information you report during abstract submission differs from the COI disclosure required during your presentation at the conference. Details on what to disclose and how to display it on the day of the conference will be announced later. Please follow those instructions.

7. Abstract Submission Instructions

7-a Word Limits and Entry Rules

• Title: up to 20 words
• Abstract: up to 250 words (abstracts exceeding the limit cannot be registered)
• Authors: up to 15, including the first author
• Affiliations: up to 15
• Figures, tables, and images are not permitted.
• Use half-width (single-byte) letters, numbers, and spaces, and left-align the text without indenting the first line.
• For the International Session, the first author is not required to be a JPCA member. Non-members are also eligible to submit abstracts.

7-b Notes on Registration

• If you need reasonable accommodations for your presentation, please describe them in the online submission system.
  e.g., Difficulty getting on and off the podium due to wheelchair use or visual impairment
  e.g., Need to wear earmuffs during the presentation due to sound sensitivity
• During the submission period, you can review, edit, or withdraw your abstract by clicking "Change registration details" and entering your abstract registration number and password. There is no limit on the number of edits.
• Each time you edit your abstract, a notification email will be sent to your registered email address. After editing, please make sure that your changes have been saved correctly.
• Your abstract registration number and password are required to review, edit, or withdraw your abstract, so please keep them in a safe place. If you forget your password, you can request a new one from the Send Password page under "Correct registration information."
• After registering, please check the layout to make sure that your title and abstract are displayed correctly.
• In principle, the Secretariat will not proofread or correct registered abstracts, including typos and other errors. Please check your abstract carefully before submitting.
• After the submission period ends, changes to the abstract and additions or changes to co-authors are not permitted.
• After registration is complete, a confirmation email will be sent to your registered email address. If you do not receive it, please contact the Secretariat.

7-c Acceptance Decision

• Notification of acceptance will be sent to your registered email address in March 2027 (tentative).

8. Abstract Submission Form

9. Inquiries

Please send inquiries regarding abstract submission to jpca2027@a-youme.jp.